Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$35.33

-0.6 (-1.67%)

09:32
06/19/17
06/19
09:32
06/19/17
09:32

Bed Bath & Beyond downgraded to Underperform from Peer Perform at Wolfe

Wolfe Research downgraded Bed Bath & Beyond to Underperform from Peer Perform with a $31 price target citing the secular shift towards online, higher capex and investment, promotional activity, and decreasing inventory productivity.

BBBY Bed Bath & Beyond
$35.33

-0.6 (-1.67%)

03/23/17
CLVD
03/23/17
NO CHANGE
Target $1025
CLVD
Bed Bath & Beyond mentioned cautiously at Cleveland Research
04/05/17
LOOP
04/05/17
NO CHANGE
LOOP
Bed Bath & Beyond Q4 report unimpressive, says Loop Capital
While Bed Bath & Beyond reported better results than Loop Capital expected, Loop analyst Anthony Chukumba noted that there was "a fairly low bar." Additionally, Chukumba, in his first glance after the Q4 report, was critical of the company's continuing trend of "anemic" top line growth, its continuing year-over-year gross margin declines, and the company's disappointing FY17 EPS guidance. The analyst rates Bed Bath & Beyond a Sell with a $35 price target.
05/12/17
LOOP
05/12/17
UPGRADE
Target $35
LOOP
Hold
Bed Bath & Beyond upgraded to Hold from Sell at Loop Capital
Loop Capital analyst Anthony Chukumba upgraded Bed Bath & Beyond to Hold with an unchanged price target of $35. The analyst cites valuation, not a more bullish view of the company's fundamentals, for the upgrade.
05/12/17
05/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tiffany (TIF) upgraded to Buy from Neutral at Goldman Sachs analyst Lindsay Drucker Mann saying the luxury category is improving amid higher international tourist spending and a "firming" high-end U.S. consumer. 2. Bed Bath & Beyond (BBBY) upgraded to Hold from Sell at Loop Capital with analyst Anthony Chukumba citing valuation, not a more bullish view of the company's fundamentals, for the upgrade. 3. Chemours (CC) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the stock's multiple can expand given the company's longer-term growth opportunities. Chemours has a proprietary set of "very profitable newer generation refrigerants with patent lives extending to 2022 with excellent growth potential," Zekauskas tells investors in a research note. He raised his price target for the shares to $50 from $39. 4. TripAdvisor (TRIP) upgraded to Long-Term Buy from Neutral at Hilliard Lyons with analyst Stephen Turner citing improving underlying performance following the first quarter report. 5. Wynn Resorts (WYNN) and Las Vegas Sands (LVS) were upgraded to Overweight from Equal Weight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

, AMGN

Amgen

$186.47

-1 (-0.53%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Hot Stocks
Cytokinetics doses first patient in Japan in GALACTIC-HF Phase 3 trial »

Cytokinetics announced…

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

AMGN

Amgen

$186.47

-1 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

KORS

Michael Kors

$44.65

-0.27 (-0.60%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Technical Analysis
Technical View: Michael Kors moves higher, analyst action »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Periodicals
Intel Capital invested over $1B in AI-focused companies, TechCrunch says »

Intel has invested more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 05

    Oct

PDCO

Patterson Companies

$37.94

-0.59 (-1.53%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Initiation
Patterson Companies initiated  »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$179.98

3.28 (1.86%)

, BSTI

BEST Inc

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Syndicate
BEST Inc cuts size of proposed IPO following 'tepid' response, Reuters reports »

Best Inc (BSTI), a…

BABA

Alibaba

$179.98

3.28 (1.86%)

BSTI

BEST Inc

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

FOLD

Amicus

$13.67

-0.21 (-1.51%)

07:42
09/19/17
09/19
07:42
09/19/17
07:42
Hot Stocks
Amicus granted FDA Fast Track Designation for migalastat »

Amicus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$2.73

0.1 (3.80%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Initiation
Rite Aid initiated  »

Rite Aid initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MDGL

Madrigal Pharmaceuticals

$19.80

0.99 (5.26%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Hot Stocks
Madrigal Pharmaceuticals announces positive outcome from pre-planned DSMB review »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDSO

Medidata

$75.85

-0.01 (-0.01%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Initiation
Medidata initiated  »

Medidata initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.34

0.26 (0.38%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Periodicals
Portola blood thinner launch could be complicated by guidelines, STAT News says »

The commercial launch of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

CRL

Charles River

$107.29

1.27 (1.20%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Initiation
Charles River initiated  »

Charles River initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Hot Stocks
Post Holdings to acquire Bob Evans for $77.00 per share »

Post Holdings (POST) and…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.01

-1.63 (-0.95%)

, AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Periodicals
FB design head touts voice command, stays silent on hardware, TechCrunch says »

Facebook (FB) head of…

FB

Facebook

$170.01

-1.63 (-0.95%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OA

Orbital ATK

$132.25

22.21 (20.18%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Downgrade
Orbital ATK rating change  »

Orbital ATK downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$187.55

7.44 (4.13%)

, FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NVDA

Nvidia

$187.55

7.44 (4.13%)

FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

WFC

Wells Fargo

$52.71

1.05 (2.03%)

V

Visa

$104.83

-0.47 (-0.45%)

HIMX

Himax

$10.70

0.15 (1.42%)

COP

ConocoPhillips

$47.09

0.58 (1.25%)

STX

Seagate

$33.52

-0.03 (-0.09%)

MOS

Mosaic

$21.31

0.65 (3.15%)

TMUS

T-Mobile

$61.80

0.63 (1.03%)

FCAU

Fiat Chrysler

$16.82

0.16 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 12

    Oct

  • 29

    Nov

  • 15

    Jan

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

, ANTM

Anthem

$185.00

-1.59 (-0.85%)

07:34
09/19/17
09/19
07:34
09/19/17
07:34
Initiation
Express Scripts, Anthem initiated  »

Express Scripts initiated…

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

ANTM

Anthem

$185.00

-1.59 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 25

    Oct

WBS

Webster Financial

$48.71

0.73 (1.52%)

07:33
09/19/17
09/19
07:33
09/19/17
07:33
Hot Stocks
Webster Financial announces CEO succession »

Webster Financial's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AAPL

Apple

$158.67

-1.21 (-0.76%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.